Sex differences in the management of atherosclerotic cardiovascular disease

Jessica N Holtzman1, Gurleen Kaur2, Breanna Hansen3

  • 1Department of Medicine, University of California, San Francisco, San Francisco, CA, USA.

Atherosclerosis
|September 18, 2023
PubMed

Insights

Women face persistent disparities in atherosclerotic cardiovascular disease (ASCVD) diagnosis, treatment, and outcomes compared to men. Addressing these sex-based differences and improving care are crucial for better cardiovascular health in women.

Area of Science:

  • Cardiology
  • Cardiovascular Disease Research
  • Sex-Based Health Differences

Background:

  • Persistent disparities exist in the diagnosis, treatment, and prognosis of atherosclerotic cardiovascular disease (ASCVD) between women and men.
  • Despite increased focus on sex-based differences, short- and long-term cardiovascular outcomes remain unequal.
  • These disparities necessitate investigation into pathophysiologic variations influencing treatment for various acute coronary syndromes (ACS) and myocardial infarction with non-obstructive coronary arteries (MINOCA).

Purpose of the Study:

  • To review existing data on differential treatment guidelines, care implementation, and cardiovascular outcomes between women and men.
  • To highlight the impact of age as an effect modifier in ACS outcomes for younger women.
  • To identify future research directions for improving cardiovascular care in women.

Main Methods:

  • Literature review of existing data on sex-based disparities in ASCVD.
  • Analysis of treatment patterns and outcomes across different acute coronary syndromes (ACS).
  • Consideration of age as a modifying factor in cardiovascular events.

Main Results:

  • Young women diagnosed with ACS exhibit higher in-hospital mortality and major adverse cardiovascular events.
  • Inadequate representation of women in clinical trials hinders evidence-based therapy implementation.
  • Evidence supports the efficacy and safety of cardiovascular medications in women across ACS spectrum.

Conclusions:

  • Addressing sex-based disparities in ASCVD is critical for improving cardiovascular care.
  • Both patient-centered and system-level interventions are essential for enhancing outcomes.
  • Further clinical investigation is needed to close the gap in cardiovascular care for women.

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
12
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
21
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
20
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
11
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
23
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
11